A short and intensive single-agent cisplatin regimen for recurrent carcinoma of the uterine cervix

International Journal of Gynecological Cancer

Volumn 6, Issue 1, 1996, Pages 61-67

  Daly, M ^a   Cowie, V J ^b   Davis, J A ^c   Habeshaw, T ^a   Junor, E J ^a   Paul, J ^a   Pyper, E ^a   Reed, N S ^a   Soukop, M ^d   Yosef, H ^a   Symonds, R P ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

carcinoma; cisplatin; intensive chemotherapy; uterine cervix

Indexed keywords

BLEOMYCIN; CISPLATIN; IFOSFAMIDE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; METASTASIS; PRIORITY JOURNAL; RECURRENT CANCER; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 9044251596     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06010061.x     Document Type: Article

References (21)

1. Bezwoda WR, Nissenbaum M, Derman DP. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomized trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate. Medical Pediatr Oncol 1986; 14: 17-19.
2. Guthrie D. Chemotherapy of cervical cancer. Clin Obstet Gynecol 1985; 12: 229-46.
3. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix - a review. Int J Gynecol Cancer 1993; 3: 129-42.
4. Alberts DS, Kronmal R, Baker LH, et al. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study. J Clin Oncol 1987; 5(11): 1791-5.
5. Levi JA, Wheeler HR, Friedlander M, Tattersall MHN, Kefford R, Dalley D. Dual sequential non-cross-resistant chemotherapy for advanced stage squamous carcimona of the cervix. Gynecol Oncol 1992; 45: 329-33.
6. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major F. Randomized trial of 3 cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecological Oncology Group Study. J Clin Oncol 1985; 3(8): 1079-85.
7. Piver MS, Barlow JJ, Lele SB, Maniccia M. Weekly cisdiamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix. Gynecol Oncol 1984; 18: 313-9.
8. Lele SB, Piver MS. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma. Gynecol Oncol 1989; 33: 6-8.
9. Crockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
10. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials, 1st edn. Oxford, UK: Blackwell Scientific Publications, 1987: 178-96.
11. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford, UK: Blackwell Scientific Publications, 1987: 428-33.
12. Ramm K, Vergote IB, Kaern J, Trope CG. Bleomycin-Ifosfamide-cisPlatinum (BIP) in pelvic recurrence of previously irradiated cervical carcimoma: a second look. Gynecol Oncol 1992; 46: 203-7.
13. Potter ME, Hatch KD, Potter MY, Shingleton HS, Baker VV. Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 1989; 63: 1283-6.
14. Blackledge G, Buxton EJ, Mould JJ, et al. Phase II studies of ifosfamide alone and in combination in cancer of the cervix. Cancer Chemother Pharmacol 1990; 26: 59-62.
15. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix-an update. Semin Oncol 1991; 18 (Suppl. 3): 11-24.
16. Giannone L, Brenner DE, Jones HW, Greco FA, Burnett LS. Combination chemotherapy for patients with advanced carcinoma of the cervix: Trial of mitomycin-C, vincristine, bleomycin and cisplatin. Gynecol Oncol 1987; 26: 178-82.
17. Muscato MS, Perry MC, Yarbro JW. Chemotherapy of cervical carcinoma. Semin Oncol 1982; 9(3): 373-87.
18. Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer. A review. Cancer 1993; 71 (Suppl. 4): 1446-50.
19. Symonds RP, Burnett RA, Habeshaw T, Kaye SB, Snee MP, Watson ER. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of the cervix. Br J Cancer 1989; 59: 473-5.
20. Thigpen JT, Shingleton H, Homesley H, Lagasse L, Blessing J. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981; 48: 899-903.
21. Chambers SC, Lamb L, Kohorn EI, Schwartz PE, Chambers JT. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol. Gynecol Oncol 1994; 53: 161-9.